MD Stem Cells

MD Stem Cells is the sponsor of Institutional Review Board (IRB) approved, National Institutes of Health (NIH) registered studies using autologous (from the same patient) Bone Marrow Derived Stem Cells (BMSC). Current studies encompass Ophthalmology, Neurology, and Spinal Cord Injury/ Paraplegia. 

MD Stem Cells publishes extensively in peer-reviewed, high quality medical and scientific publications. MD Stem Cells provides the only available, proven treatment using BMSC for Non-arteritic ischemic optic neuropathy (NAION) also called a stroke of the optic nerve. They provide the only available, proven treatment for Retinitis Pigmentosa (RP). Both have proven findings that are statistically significant.